Psoriasis flares after COVID-19 vaccination: adherence to biologic therapy reduces psoriasis exacerbations: a case-control study
10.7774/cevr.2023.12.1.80
- Author:
Martina BURLANDO
1
;
Astrid HERZUM
;
Emanuele COZZANI
;
Aurora PARODI
Author Information
1. Section of Dermatology, Department of Health Sciences (DISSAL), San Martino Polyclinic Hospital IRCCS, University of Genoa, Genoa, Italy
- Publication Type:Brief Communication
- From:Clinical and Experimental Vaccine Research
2023;12(1):80-81
- CountryRepublic of Korea
- Language:English
-
Abstract:
This study aimed to evaluate if patients under biologics have a lower risk of psoriasis flares after coronavirus disease 2019 (COVID-19) vaccination than other psoriatic patients. Of 322 recently vaccinated patients admitted for psoriasis at the Dermatological Psoriasis Unit during January and February 2022, 316 (98%) had no psoriasis flares after COVID-19 vaccination (79% under biologic treatment, 21% not biologically treated) and 6 (2%) presented psoriasis flares after COVID-19 vaccination (33.3% under biologic treatment, 66.6% not biologically treated). Overall, psoriasis patients under biologic treatment, developed fewer psoriasis flares after COVID-19 vaccination (33.3%), than patients not under biologic treatment (66.6%) (p=0.0207; Fisher’s exact test).
